×

BioMarin CEO on drug pricing, approval

1:13 PM ET Tue, 12 Jan 2016

BioMarin CEO Jean-Jacques Bienaime, discusses drug pricing, the sentiment of investors in biotech and his expectations for the company's Duchenne muscular dystrophy drug.